OTX-2002
omega Theraputics
$omga omega therapeutics presents new preclinical data supporting the first epigenomic controller, otx-2002, as a potential therapeutic approach in hepatocellular carcinoma at the esmo 2022 world congress on gastroin #cancer
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft